UBM EMEA has celebrated the closing of two Asian events, said to be the largest pharmaceutical events in their respective regions.
CPhI Russia (30 March – 1 April) and CPhI South East Asia, (6-8 April) celebrate the closing of two successful Asian events – the largest pharma events in their respective regions.
CPhI South East Asia 2016 saw 4,740 attendees from 41 countries and witnessed a participation of 260 exhibitors from 25 countries. Meanwhile, CPhI Russia in turn, welcomed 199 exhibitors and attracted over 3,000 attendees from 63 countries across the globe.
“With now five market-leading events in Asia, CPhI Russia and CPhI South East Asia demonstrate the continued growth and recognition of the CPhI portfolio around the globe. Much of this is due to our ability to provide practical and innovative solutions tailored to regional markets – both from an exhibitor and, just as crucially, from a visitor perspective,” said Chris Kilbee, group director Pharma at UBM EMEA.
